<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2023.1267656</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of mentalizing in the relationship between schizotypal personality traits and state signs of psychosis risk captured by cognitive and perceptive basic symptoms</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Salaminios</surname>
<given-names>George</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<xref rid="fn0001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/329567/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spr&#x00FC;ngli-Toffel</surname>
<given-names>Elodie</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
<xref rid="aff6" ref-type="aff"><sup>6</sup></xref>
<xref rid="fn0001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Michel</surname>
<given-names>Chantal</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff7" ref-type="aff"><sup>7</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/299168/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morosan</surname>
<given-names>Larisa</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/748813/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eliez</surname>
<given-names>Stephan</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/11212/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition"/>
<role content-type="https://credit.niso.org/contributor-roles/resources"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Armando</surname>
<given-names>Marco</given-names>
</name>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/565025/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fonseca-Pedrero</surname>
<given-names>Eduardo</given-names>
</name>
<xref rid="aff8" ref-type="aff"><sup>8</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/175369/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Derome</surname>
<given-names>Melodie</given-names>
</name>
<xref rid="aff9" ref-type="aff"><sup>9</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schultze-Lutter</surname>
<given-names>Frauke</given-names>
</name>
<xref rid="aff7" ref-type="aff"><sup>7</sup></xref>
<xref rid="aff10" ref-type="aff"><sup>10</sup></xref>
<xref rid="aff11" ref-type="aff"><sup>11</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/268898/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Debban&#x00E9;</surname>
<given-names>Martin</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/11211/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition"/>
<role content-type="https://credit.niso.org/contributor-roles/resources"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Research Department of Clinical, Educational and Health Psychology, University College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff2"><sup>2</sup><institution>Research Department, British Association for Counselling and Psychotherapy</institution>, <addr-line>Lutterworth</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff3"><sup>3</sup><institution>Developmental Clinical Psychology Research Unit, Faculty of Psychology and Educational Sciences, University of Geneva</institution>, <addr-line>Geneva</addr-line>, <country>Switzerland</country></aff>
<aff id="aff4"><sup>4</sup><institution>Developmental Imaging and Psychopathology Lab, Department of Psychiatry, University of Geneva School of Medicine</institution>, <addr-line>Geneva</addr-line>, <country>Switzerland</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Psychiatry, Lausanne University Hospital (CHUV)</institution>, <addr-line>Lausanne</addr-line>, <country>Switzerland</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Psychiatry, University of Geneva</institution>, <addr-line>Geneva</addr-line>, <country>Switzerland</country></aff>
<aff id="aff7"><sup>7</sup><institution>University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern</institution>, <addr-line>Bern</addr-line>, <country>Switzerland</country></aff>
<aff id="aff8"><sup>8</sup><institution>Department of Educational Sciences, University of La Rioja</institution>, <addr-line>La Rioja</addr-line>, <country>Spain</country></aff>
<aff id="aff9"><sup>9</sup><institution>Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern</institution>, <addr-line>Bern</addr-line>, <country>Switzerland</country></aff>
<aff id="aff10"><sup>10</sup><institution>Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University</institution>, <addr-line>D&#x00FC;sseldorf</addr-line>, <country>Germany</country></aff>
<aff id="aff11"><sup>11</sup><institution>Department of Psychology, Faculty of Psychology, Airlangga University</institution>, <addr-line>Surabaya</addr-line>, <country>Indonesia</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Massoud Stephane, Oregon Health and Science University, United States</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Lucia Sideli, Libera Universit&#x00E0; Maria SS. Assunta, Italy; Cherise Rosen, University of Illinois Chicago, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: George Salaminios, <email>g.salaminios@ucl.ac.uk</email></corresp>
<fn fn-type="equal" id="fn0001">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1267656</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Salaminios, Spr&#x00FC;ngli-Toffel, Michel, Morosan, Eliez, Armando, Fonseca-Pedrero, Derome, Schultze-Lutter and Debban&#x00E9;.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Salaminios, Spr&#x00FC;ngli-Toffel, Michel, Morosan, Eliez, Armando, Fonseca-Pedrero, Derome, Schultze-Lutter and Debban&#x00E9;</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Objective</title>
<p>Schizotypal traits and disturbances in mentalizing (the capacity to understand the mental states driving one&#x2019;s own and others&#x2019; behaviors) have been implicated in increased vulnerability for psychosis. Therefore, we explored the associations linking schizotypal traits, mentalizing difficulties and their interactions to clinical high-risk for psychosis (CHR-P), as captured by the Basic Symptoms (BS) approach, during adolescence and young adulthood.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>Eighty-seven adolescents and young adults from the general population (46% male, 44% female; age: 14&#x2013;23&#x2009;years) were assessed with the Schizophrenia Proneness Interview (SPI-CY/A) for 11 perceptive and cognitive BS, with the Schizotypal Personality Questionnaire (SPQ) for schizotypal traits, and with the Reflective Functioning Questionnaire (RFQ) for self-reported mentalizing abilities. The RFQ evaluates the level of certainty (RFQc scale) and uncertainty (RFQu scale) with which individuals use mental state information to explain their own and others&#x2019; behaviors.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>Logistic regression models showed significant positive effects of the SPQ disorganization scale on perceptive BS and of the SPQ interpersonal scale on cognitive BS. Post-hoc analyses revealed that schizotypal features pertaining to odd speech and social anxiety, respectively, were associated with perceptive and cognitive BS. Furthermore, higher scores on the RFQu scale and lower scores on the RFQc scale independently explained the presence of cognitive BS. Finally, significant interaction effects between RFQc and SPQ odd speech on perceptive BS, and between RFQc and SPQ social anxiety on cognitive BS were found.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Our findings suggest that schizotypal traits and mentalizing significantly relate both independently and through their interactions to the presence of cognitive and perceptive BS included in CHR-P criteria. Furthermore, mentalizing dysfunction may contribute in the relation between schizotypal traits and early state signs of CHR-P. Mentalizing may support both detection and early treatment of CHR-P among adolescents and young adults who present with trait risk for psychosis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>mentalization</kwd>
<kwd>schizotypy</kwd>
<kwd>basic symptoms</kwd>
<kwd>psychosis</kwd>
<kwd>CHR</kwd>
<kwd>reflective functioning</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="59"/>
<page-count count="10"/>
<word-count count="7941"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Schizophrenia</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1.</label>
<title>Introduction</title>
<p>Contemporary research suggests that clinical psychosis is a neurodevelopmental disorder that commonly emerges during late adolescence/young adulthood, and is preceded by premorbid and prodromal aberrations manifesting primarily within the perceptual, interpersonal and cognitive domains (<xref ref-type="bibr" rid="ref1">1</xref>). In doing so, psychosis is expressed along a continuum ranging from relatively stable trait abnormalities, to sub-clinical psychotic manifestations of lesser severity and duration, and finally to the severe reality distortions typically identified in people diagnosed with the clinical form of the illness (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref3">3</xref>). Importantly, the transition from premorbid and prodromal psychotic manifestations to a clinically diagnosable form of psychosis has been linked to adverse outcomes in social, interpersonal, and occupational functioning that often persist despite symptomatic improvement following psychological or pharmacological treatment (<xref ref-type="bibr" rid="ref4">4</xref>). For this reason, the focus of clinical intervention is progressively shifting toward a more preventative approach, seeking to identify and treat risk for psychosis during its premorbid and assumed prodromal stages, i.e., the clinical high-risk (CHR-P) stage, prior to the onset of the first clinical episode (<xref ref-type="bibr" rid="ref5">5</xref>). Several studies suggest that early intervention might improve outcomes and reduce illness-related costs (<xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref7">7</xref>). However, the psychological processes that are involved in the earliest stages of psychosis expression and should be targeted early to prevent the onset of clinical illness remain unclear (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>Two main approaches have been developed for the assessment of the CHR-P stage that most proximally precedes the onset of clinical psychosis: the ultra-high risk (UHR) and the basic symptoms (BS) approaches (<xref ref-type="bibr" rid="ref9">9</xref>). Although both approaches focus on the detection of newly emergent CHR-P states conferring proximal vulnerability for transition to psychotic disorders, they differ in terms of the manifestations they seek to capture. First, the UHR paradigm primarily relies on the assessment of positive psychotic manifestations (e.g., unusual thought content, persecutory ideas, grandiosity, perceptual abnormalities and disorganized speech) that are too brief or not severe enough for a psychiatric diagnosis of clinical psychosis (<xref ref-type="bibr" rid="ref10">10</xref>). In contrast, the BS approach relies on the assessment of a wider range of subtle, subjectively experienced shifts in cognitive and perceptual processes, including but not restricted to experiences of thought interference, unstable ideas of reference, attentional problems and language difficulties (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>). As such, the assessment of BS has been suggested as a complementary approach that can support the detection of the earliest CHR-P states, prior to the development of attenuated psychotic symptoms (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>).</p>
<p>Overall, the UHR and BS approaches have been shown to be sensitive in capturing proximal risk for conversion to clinical psychosis among help-seeking populations, with conversion rates ranging between 15.0% at one year to 29.1% at three years for UHR criteria, and between 25.3% at one year to 50.0% at three years for the BS &#x201C;cognitive disturbances&#x201D; (COGDIS) criterion (<xref ref-type="bibr" rid="ref9">9</xref>). Yet, conversion rates seem to have generally declined in CHR-P samples in recent years (<xref ref-type="bibr" rid="ref13">13</xref>). At present, the alternative assessment of the two symptomatic UHR criteria based on attenuated and transient psychotic symptoms and COGDIS have been recommended for clinical use (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref14">14</xref>) to support the timely application of indicated treatments to attenuate the risk for conversion to clinical psychosis (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). Importantly however, beyond the risk of clinical psychosis, CHR-P patients who do not transition to psychotic disorders have been repeatedly reported to have adverse mental health and functional outcomes, including poor social functioning, persistence or development of non-psychotic mental health disorders, and non-remission of CHR-P symptoms (<xref ref-type="bibr" rid="ref17">17</xref>). Thus, from a clinical perspective, further elucidating the factors, including premorbid vulnerability traits (<xref ref-type="bibr" rid="ref18">18</xref>), that may potentiate or attenuate psychosis risk will support the application of targeted early prevention treatment approaches aiming to attenuate clinical trajectories at the earliest stages of their expression.</p>
<p>Current approaches to study the first signs of psychosis in non-clinical populations are based on the psychometric evaluation of schizotypal personality traits that capture the phenotypic expression of the underlying genetic liability for schizophrenia-spectrum disorders (<xref ref-type="bibr" rid="ref19">19</xref>, <xref ref-type="bibr" rid="ref20">20</xref>). Contrary to the symptomatic CHR-P states, schizotypal traits are subjectively recognized by individuals as common aspects of their personality functioning (<xref ref-type="bibr" rid="ref21 ref22 ref23">21&#x2013;23</xref>). Most psychometric analyses examining the factorial structure of schizotypal traits typically identify three dimensions: a cognitive-perceptual (positive schizotypy: hallucination and delusion-like phenomena), an interpersonal (negative schizotypy: social anxiety, constricted affect) and a disorganization dimension (odd behaviors and speech) (<xref ref-type="bibr" rid="ref22">22</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). Longitudinal research with study intervals spanning from 5 to 50 years suggests that self-reported schizotypal manifestations represent distal trait markers for the development of psychotic disorders, with heightened negative schizotypy identified as the most consistently reported distal predictor of conversion to psychosis in CHR-P samples (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref22">22</xref>, <xref ref-type="bibr" rid="ref25">25</xref>).</p>
<p>Although schizotypal traits have been related to CHR-P states (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref26">26</xref>), not all people exhibiting schizotypal trait manifestations develop more dysfunctional or clinically relevant psychotic states (<xref ref-type="bibr" rid="ref27">27</xref>). Indeed, according to most conceptual models, schizotypal traits are not assumed to be sufficient to indicate risk for clinical psychopathology (<xref ref-type="bibr" rid="ref22">22</xref>, <xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>). Rather, state manifestations of psychosis risk, such as those captured by the UHR and BS approaches, may represent clinical exacerbations of schizotypal personality traits; while a second source of risk may emanate from additional neurobiological aberrations (<xref ref-type="bibr" rid="ref29">29</xref>, <xref ref-type="bibr" rid="ref30">30</xref>). This was recently empirically supported (<xref ref-type="bibr" rid="ref23">23</xref>), yet, the psychological factors that may potentiate the transition from non-clinical schizotypal manifestations to the earliest state signs of psychosis risk, such as self-experienced cognitive and perceptual BS, remain unclear.</p>
<p>An important psychological factor mitigating the development of risk states for psychosis may be mentalizing - the capacity to perceive or interpret one&#x2019;s own and others&#x2019; behaviors, as being driven by intentional mental states, such as thoughts and feelings (<xref ref-type="bibr" rid="ref31 ref32 ref33 ref34">31&#x2013;34</xref>). Mentalizing constitutes a multifaceted construct that captures attempts to make sense of oneself and others in terms of subjective mental states. In doing so, mentalizing enables us to form representational models of human behavior in order to adaptively navigate the complexity of the social world, as well as monitor and regulate our own thinking and feeling states (<xref ref-type="bibr" rid="ref31">31</xref>). Meta-analyses indicate that both schizophrenia and CHR-P patients exhibit dysfunctions in multiple domains of mentalizing (<xref ref-type="bibr" rid="ref35">35</xref>, <xref ref-type="bibr" rid="ref36">36</xref>). More recently, a longitudinal study showed that mentalizing abilities, assessed through the use of narrative-based methodologies, significantly predicted conversion to clinical psychosis in a CHR-P sample (<xref ref-type="bibr" rid="ref37">37</xref>). Importantly, another line of research indicates that subtle mentalizing difficulties are already present among non-clinical adult and adolescent samples who report schizotypal traits, prior to the development of clinical state manifestations, suggesting an early pathway toward illness expression (<xref ref-type="bibr" rid="ref38 ref39 ref40">38&#x2013;40</xref>). Furthermore, evidence suggest that mentalizing difficulties among adolescents who report schizotypal trait manifestations may contribute to the emergence of clinically-relevant symptoms, including thought problems and delusional ideation (<xref ref-type="bibr" rid="ref38">38</xref>, <xref ref-type="bibr" rid="ref41">41</xref>). Thus, previous findings among both CHR-P and non-clinical samples highlight that mentalizing may play a role in modulating the trajectory of emerging psychosis across the developmental continuum of its expression.</p>
<p>However, to the best of our knowledge, the relationships between schizotypal traits, mentalizing dysfunction, and early state manifestations of psychosis risk, such as those captured by BS criteria, have yet to be simultaneously examined. Elucidating the nature of associations linking schizotypal traits and mentalizing difficulties to the presence of state manifestations relevant for psychosis during the critical developmental window from adolescence to young adulthood may contribute to inform early prevention treatment strategies aiming to attenuate the trajectory of emerging psychosis at its earliest stages.</p>
<p>Thus, the present study seeks to (a) assess the associations of schizotypal traits and self-reported mentalizing with the presence of cognitive and perceptive BS in a sample of community adolescents and young adults, and (b) examine whether schizotypal traits interact with mentalizing difficulties to account for the presence of cognitive and perceptive BS. On the basis of previous research suggesting that schizotypal traits and mentalizing dysfunctions are liked with psychotic symptoms among CHR-P samples (<xref ref-type="bibr" rid="ref26">26</xref>, <xref ref-type="bibr" rid="ref37">37</xref>), we hypothesized that schizotypal traits and self-reported mentalizing difficulties (i.e., high uncertainty and low certainty in mental states) would be independently associated with the presence of both perceptive and cognitive BS. Furthermore, given that mentalizing has been proposed as a psychological factor that may modulate CHR-P among individuals who exhibit premorbid schizotypal trait manifestations (<xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref37">37</xref>), we hypothesized that schizotypal traits would account for the presence of cognitive and perceptive BS in the presence of mentalizing difficulties.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<label>2.</label>
<title>Materials and methods</title>
<sec id="sec7">
<label>2.1.</label>
<title>Participants and procedure</title>
<p>Eighty-seven community adolescents and young adults (47 female, 40 males), aged 14 to 23&#x2009;years (<italic>M</italic>&#x2009;=&#x2009;19.27, SD&#x2009;=&#x2009;2.09) were recruited <italic>via</italic> written advertisements in public schools, universities and community centers in the city of Geneva, Switzerland. None of the participants suffered from past/present psychiatric disorders, or neurodevelopmental disorders (e.g., autism spectrum disorder). Written informed consent was obtained from all participants and legal guardians of those under 18&#x2009;years of age.</p>
</sec>
<sec id="sec8">
<label>2.2.</label>
<title>Measures</title>
<p><italic>The Schizotypal Personality Questionnaire</italic> (SPQ) (<xref ref-type="bibr" rid="ref42">42</xref>) measures schizotypal traits subjectively experienced as common aspects of one&#x2019;s personality functioning. It yields three dimensional scores and nine subscale scores: cognitive-perceptual (unusual perceptual experiences, ideas of reference, suspiciousness, odd beliefs or magical thinking), interpersonal (social anxiety, constricted affect, lack of close friends) and disorganization (odd speech, odd behaviors). The French version of the SPQ has shown good reliability (Cronbach&#x2019;s alpha&#x2009;=&#x2009;0.91) (<xref ref-type="bibr" rid="ref42">42</xref>) and has been validated for French-speaking adolescents (<xref ref-type="bibr" rid="ref43">43</xref>).</p>
<p>Mentalizing was assessed using the French version of the <italic>Reflective Functioning Questionnaire</italic> (RFQ) (<xref ref-type="bibr" rid="ref44">44</xref>). The RFQ is a brief and easy to administer measure that assesses participants&#x2019; self-reported certainty and uncertainty about mental states, reflecting how confident vs. how doubtful one is in utilizing mental state information, such as thoughts and feelings, to explain their own and others&#x2019; behaviors. Items are scored on a seven-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree). The <italic>uncertainty about mental states</italic> subscale (RFQu) focuses on the extent to which individuals agree with statements such as &#x2018;Other people&#x2019;s thoughts are a mystery to me&#x2019; and &#x2018;Strong feelings often cloud my thinking&#x2019;. High scores on the RFQu reflect poor usage of mental state information and a stance characterized by a lack of knowledge about mental states. The <italic>certainty about mental states</italic> subscale (RFQc) focuses on the extent to which individuals disagree with statements such as &#x2018;I do not always know why I do what I do&#x2019;. RFQc items are recoded so that high scores reflect better usage of mental state information and adaptive levels of certainty about mental states. The RFQ has been shown to correlate with measures of mindfulness, perspective-taking and empathy (<xref ref-type="bibr" rid="ref45">45</xref>) and its brief nature makes it a suitable assessment tool for the purposes outcome evaluation in the context of clinical settings and clinical trials. The RFQ has been validated for French-speaking adolescents (<xref ref-type="bibr" rid="ref44">44</xref>) showing satisfactory reliability for both the RFQu (Cronbach&#x2019;s alpha =0.68) and the RFQc scale (Cronbach&#x2019;s alpha&#x2009;=&#x2009;0.74).</p>
<p><italic>The Schizophrenia Proneness Instrument, Adult version</italic> (SPI-A) (<xref ref-type="bibr" rid="ref46">46</xref>) for participants aged &#x2265;18&#x2009;years and the <italic>Child &#x0026; Youth version</italic> SPI-CY (<xref ref-type="bibr" rid="ref47">47</xref>) for participants aged &#x003C;18&#x2009;years were used to assess the presence of cognitive and perceptive symptoms included in BS criteria that are equal in both versions. COGDIS captures nine cognitive BS (i.e., inability to divide attention, captivation of attention by details of the visual field, thought interference, thought pressure, thought blockages, disturbances of receptive speech, disturbances of expressive speech, disturbances of abstract thinking, unstable ideas of reference). All nine cognitive symptoms from COGDIS were assessed in the current study. In addition to these, COPER also captures two perceptive BS (i.e., visual and acoustic perception disturbances). Because the current study focused on differentiating between cognitive and perceptive symptoms, we also included COPER items that assess the two perceptive symptoms but, for the current recommendation of only COGDIS for clinical use (<xref ref-type="bibr" rid="ref9">9</xref>), excluded cognitive BS included in COPER only (i.e., thought pressure, derealization, and decreased ability to discriminate between ideas and perception, fantasy and true memories). SPI-A/CY rate cognitive and perceptive BS for the maximum frequency of their occurrence within the past 3&#x2009;months ranging from 0 (BS has not occurred in the past 3&#x2009;months) to 6 (BS has occurred daily within the past 3&#x2009;months). For the purposes of the current study, which only included participants from the general population, BS item scores on the SPI-A/CY were recoded as categorical variables according to their presence or absence: a score of 0 signified the <italic>absence</italic> of the BS (assigned to scores of 0), while a score of 1 signified the <italic>presence</italic> of the BS (assigned to all scores between 1 and 6). According to rating rules, symptoms that were reported as occurring unchanged throughout life (i.e., a score of 7), were also assigned a score of 0 for not representing a risk state manifestation. Finally, sum scores of the two dichotomized perceptive BS scores and the nine dichotomized cognitive BS scores were calculated and again dichotomized (0&#x2009;=&#x2009;0 and&#x2009;&#x2265;&#x2009;1&#x2009;=&#x2009;1) to indicate the presence/absence of any perceptive or cognitive BS.</p>
</sec>
<sec id="sec9">
<label>2.3.</label>
<title>Statistical analyses</title>
<p>SPSS 23.0 was used for data analyses. Multivariate logistic regressions were performed to assess the effects of SPQ and RFQ scores as well as their interactions on the presence of perceptive and cognitive BS. In order to allow comparisons between variables, SPQ and RFQ continuous scores were transformed into <italic>z</italic> scores. Because participant gender, age, education level and nationality were not significantly associated with the presence of cognitive and perceptive BS in the current sample, these were not entered as covariates in the analyses.</p>
<p>First, two multivariate logistic regression analyses were conducted using the enter method to examine the effects of the three SPQ dimensions on perceptive and cognitive BS. In the first model, all SPQ scales were entered together as independent variables and perceptive BS was entered as the dependent variable, while in the second model, cognitive BS was entered as the dependent variable. Next, post-hoc regression analyses were conducted using the enter method to examine which subscales of each significant SPQ dimension drove the effect on perceptive and cognitive BS.</p>
<p>Second, two multivariate logistic regression analyses were conducted using the enter method to examine the effects of RFQ scales (RFQu and RFQc) on perceptive and cognitive BS. The two RFQ scales were entered as independent variables in each model, while perceptive and cognitive BS scores were entered as dependent variables in each model, respectively.</p>
<p>Finally, multivariate logistic regression analyses using the enter method were conducted in order to uncover possible interaction effects between SPQ subscales and RFQ scales on perceptive and cognitive BS. SPQ subscales shown to have a significant independent effect on perceptive and cognitive BS in the previous analyses, along with RFQ scales were used in the models as predictors.</p>
</sec>
</sec>
<sec sec-type="results" id="sec10">
<label>3.</label>
<title>Results</title>
<sec id="sec11">
<label>3.1.</label>
<title>Descriptive statistics</title>
<p><xref rid="tab1" ref-type="table">Table 1</xref> presents the demographic data of the sample, the frequency of perceptive and cognitive BS, as well as the mean z scores for the SPQ and RFQ scales. While low-frequency BS were common (<xref rid="tab1" ref-type="table">Table 1</xref>), only 1.1% of participants fulfilled COGDIS requirements, and 9.2% COPER requirements for CHR-P.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Distributions and means of socio-demographic and clinical variables.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Socio-demographic variables</th>
<th align="center" valign="top">Total (<italic>N</italic>&#x2009;=&#x2009;87)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="2"><italic>Age (years)</italic></td>
</tr>
<tr>
<td align="left" valign="top">Mean (SD)</td>
<td align="char" valign="top" char=".">19.27 (2.09)</td>
</tr>
<tr>
<td align="left" valign="top">Range</td>
<td align="char" valign="top" char=".">14.04&#x2013;23.73</td>
</tr>
<tr>
<td align="left" valign="top">Sex, <italic>n</italic> (%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Female</td>
<td align="char" valign="top" char=".">47 (54%)</td>
</tr>
<tr>
<td align="left" valign="top">Male</td>
<td align="char" valign="top" char=".">40 (46%)</td>
</tr>
<tr>
<td align="left" valign="top">Nationality, <italic>n</italic> (%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Swiss</td>
<td align="char" valign="top" char=".">30 (34.5%)</td>
</tr>
<tr>
<td align="left" valign="top">Mixed including Swiss</td>
<td align="char" valign="top" char=".">22 (25.28%)</td>
</tr>
<tr>
<td align="left" valign="top">Other</td>
<td align="char" valign="top" char=".">35 (40.22%)</td>
</tr>
<tr>
<td align="left" valign="top">Parental highest education, <italic>n</italic> (%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Lower secondary education (ISCED 0&#x2013;2)</td>
<td align="char" valign="top" char=".">8 (9.20%)</td>
</tr>
<tr>
<td align="left" valign="top">Upper secondary education (ISCED 3&#x2013;7)</td>
<td align="char" valign="top" char=".">79 (90.80%)</td>
</tr>
<tr>
<td align="left" valign="top">Participant highest education, <italic>n</italic> (%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No information</td>
<td align="char" valign="top" char=".">6 (6.90%)</td>
</tr>
<tr>
<td align="left" valign="top">Lower secondary education (ISCED 0&#x2013;2)</td>
<td align="char" valign="top" char=".">34 (39,08%)</td>
</tr>
<tr>
<td align="left" valign="top">Upper secondary education (ISCED 3&#x2013;7)</td>
<td align="char" valign="top" char=".">47 (54.02%)</td>
</tr>
<tr>
<td align="left" valign="top"><italic>Participant occupational status, n (%)</italic></td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Employed</td>
<td align="char" valign="top" char=".">3 (3.45%)</td>
</tr>
<tr>
<td align="left" valign="top">Searching for employment</td>
<td align="char" valign="top" char=".">3 (3.45%)</td>
</tr>
<tr>
<td align="left" valign="top">Still in education</td>
<td align="char" valign="top" char=".">73 (83.91%)</td>
</tr>
<tr>
<td align="left" valign="top">Other</td>
<td align="char" valign="top" char=".">8 (9.19%)</td>
</tr>
<tr>
<td align="left" valign="top" char="." colspan="2"><italic>Clinical variables</italic></td>
</tr>
<tr>
<td align="left" valign="top">Any perceptive basic symptoms, <italic>n</italic> (%)</td>
<td align="char" valign="top" char=".">19 (21.80%)</td>
</tr>
<tr>
<td align="left" valign="top">Any cognitive basic symptoms, <italic>n</italic> (%)</td>
<td align="char" valign="top" char=".">31 (35.60%)</td>
</tr>
<tr>
<td align="left" valign="top">SPQ cognitive-perceptual scale, mean <italic>z</italic> score (SD)</td>
<td align="char" valign="top" char=".">&#x2212;0.04 (6.36)</td>
</tr>
<tr>
<td align="left" valign="top">SPQ interpersonal scale, mean <italic>z</italic> score (SD)</td>
<td align="char" valign="top" char=".">0.15 (4.45)</td>
</tr>
<tr>
<td align="left" valign="top">SPQ disorganized, mean <italic>z</italic> score (SD)</td>
<td align="char" valign="top" char=".">&#x2212;0.11 (3.45)</td>
</tr>
<tr>
<td align="left" valign="top">RFQu, mean <italic>z</italic> score (SD)</td>
<td align="char" valign="top" char=".">0.09 (3.44)</td>
</tr>
<tr>
<td align="left" valign="top">RFQc, mean <italic>z</italic> score (SD)</td>
<td align="char" valign="top" char=".">&#x2212;0.22 (4.52)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec12">
<label>3.2.</label>
<title>Simple effects of schizotypal traits and mentalizing on basic symptoms</title>
<p>Regression analyses of the simple effects of SPQ dimensions on the presence of perceptive or cognitive BS showed that the SPQ disorganization dimension had the only significant but weak effect on perceptive BS (<italic>&#x03B2;</italic>&#x2009;=&#x2009;0.18, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 1.09, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), while the interpersonal SPQ dimension had the only significant but weak effect on cognitive BS (<italic>&#x03B2;</italic>&#x2009;=&#x2009;0.11, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 4.52, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) (<xref rid="tab2" ref-type="table">Table 2</xref>). <italic>Post-hoc</italic> analyses demonstrated that the SPQ odd speech subscale (disorganization dimension) drove the effect on perceptive BS (<italic>&#x03B2;</italic>&#x2009;=&#x2009;0.24, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 4.47, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) and that the SPQ social anxiety subscale (interpersonal dimension) drove the effect on cognitive BS (<italic>&#x03B2;</italic>&#x2009;=&#x2009;0.31, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 9.31, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01) (<xref rid="tab3" ref-type="table">Table 3</xref>). In doing so, effects of the single subscales were slightly larger than the effects of their corresponding dimensions.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Logistic regression analyses of SPQ scales on perceptive and cognitive BS.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Dependent variables<break/>Independent variables</th>
<th align="center" valign="top"><italic>&#x03B2;</italic>
</th>
<th align="center" valign="top">SE</th>
<th align="center" valign="top">Wald (df&#x2009;=&#x2009;1)</th>
<th align="center" valign="top"><italic>p</italic></th>
<th align="center" valign="top">Exp(<italic>&#x03B2;</italic>)</th>
<th align="center" valign="top">95% CIs of Exp(<italic>&#x03B2;</italic>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="7"><italic>Perceptive BS</italic></td>
</tr>
<tr>
<td align="left" valign="top">SPQ cognitive-perceptual</td>
<td align="char" valign="top" char=".">0.06</td>
<td align="char" valign="top" char=".">0.04</td>
<td align="char" valign="top" char=".">2.27</td>
<td align="char" valign="top" char=".">0.13</td>
<td align="char" valign="top" char=".">1.06</td>
<td align="char" valign="top" char=".">0.98; 1.14</td>
</tr>
<tr>
<td align="left" valign="top">SPQ interpersonal</td>
<td align="char" valign="top" char=".">0.06</td>
<td align="char" valign="top" char=".">0.06</td>
<td align="char" valign="top" char=".">1.09</td>
<td align="char" valign="top" char=".">0.30</td>
<td align="char" valign="top" char=".">1.06</td>
<td align="char" valign="top" char=".">0.95; 1.19</td>
</tr>
<tr>
<td align="left" valign="top">SPQ disorganized</td>
<td align="char" valign="top" char=".">0.18</td>
<td align="char" valign="top" char=".">0.08</td>
<td align="char" valign="top" char=".">5.05</td>
<td align="char" valign="top" char=".">
<bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">1.20</td>
<td align="char" valign="top" char=".">1.02; 1.40</td>
</tr>
<tr>
<td align="left" valign="top" char="." colspan="7"><italic>Cognitive BS</italic></td>
</tr>
<tr>
<td align="left" valign="top">SPQ cognitive perceptual</td>
<td align="char" valign="top" char=".">&#x2212;0.03</td>
<td align="char" valign="top" char=".">0.05</td>
<td align="char" valign="top" char=".">0.48</td>
<td align="char" valign="top" char=".">0.49</td>
<td align="char" valign="top" char=".">0.97</td>
<td align="char" valign="top" char=".">0.88; 1.06</td>
</tr>
<tr>
<td align="left" valign="top">SPQ interpersonal</td>
<td align="char" valign="top" char=".">0.11</td>
<td align="char" valign="top" char=".">0.05</td>
<td align="char" valign="top" char=".">4.52</td>
<td align="char" valign="top" char=".">
<bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">1.12</td>
<td align="char" valign="top" char=".">1.01; 1.24</td>
</tr>
<tr>
<td align="left" valign="top">SPQ disorganized</td>
<td align="char" valign="top" char=".">0.05</td>
<td align="char" valign="top" char=".">0.08</td>
<td align="char" valign="top" char=".">0.29</td>
<td align="char" valign="top" char=".">0.59</td>
<td align="char" valign="top" char=".">1.05</td>
<td align="char" valign="top" char=".">0.890; 1.23</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>BS, Basic Symptoms; SPQ, Schizotypal Personality Questionnaire.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p><italic>Post-hoc</italic> regression analyses of SPQ subscales on perceptive and cognitive BS.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Dependent variables</th>
<th align="left" valign="top">Independent variables</th>
<th align="center" valign="top">&#x03B2;</th>
<th align="center" valign="top">SE</th>
<th align="center" valign="top">Wald (df&#x2009;=&#x2009;1)</th>
<th align="center" valign="top"><italic>p</italic></th>
<th align="center" valign="top">Exp(&#x03B2;)</th>
<th align="center" valign="top">95% CIs of Exp(&#x03B2;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="8"><italic>Perceptive BS</italic></td>
</tr>
<tr>
<td rowspan="2"/>
<td align="left" valign="top">SPQ odd behaviors</td>
<td align="char" valign="top" char=".">0.07</td>
<td align="char" valign="top" char=".">0.15</td>
<td align="char" valign="top" char=".">0.21</td>
<td align="char" valign="top" char=".">0.65</td>
<td align="char" valign="top" char=".">1.07</td>
<td align="char" valign="top" char=".">0.80; 1.44</td>
</tr>
<tr>
<td align="left" valign="top">SPQ odd speech</td>
<td align="char" valign="top" char=".">0.24</td>
<td align="char" valign="top" char=".">0.12</td>
<td align="char" valign="top" char=".">4.47</td>
<td align="char" valign="top" char=".">
<bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">1.28</td>
<td align="char" valign="top" char=".">1.02; 1.60</td>
</tr>
<tr>
<td align="left" valign="top" colspan="8"><italic>Cognitive BS</italic></td>
</tr>
<tr>
<td rowspan="3"/>
<td align="left" valign="top">SPQ social anxiety</td>
<td align="char" valign="top" char=".">0.31</td>
<td align="char" valign="top" char=".">0.10</td>
<td align="char" valign="top" char=".">9.3</td>
<td align="char" valign="top" char="."><bold>&#x003C;0.01</bold></td>
<td align="char" valign="top" char=".">1.37</td>
<td align="char" valign="top" char=".">1.1; 1.68</td>
</tr>
<tr>
<td align="left" valign="top">SPQ no close friends</td>
<td align="char" valign="top" char=".">&#x2212;0.16</td>
<td align="char" valign="top" char=".">0.18</td>
<td align="char" valign="top" char=".">0.81</td>
<td align="char" valign="top" char=".">0.37</td>
<td align="char" valign="top" char=".">0.85</td>
<td align="char" valign="top" char=".">0.60; 1.21</td>
</tr>
<tr>
<td align="left" valign="top">SPQ constricted affect</td>
<td align="char" valign="top" char=".">&#x2212;0.01</td>
<td align="char" valign="top" char=".">0.22</td>
<td align="char" valign="top" char=".">0.00</td>
<td align="char" valign="top" char=".">0.98</td>
<td align="char" valign="top" char=".">0.10</td>
<td align="char" valign="top" char=".">0.65; 1.53</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>BS, Basic Symptoms; SPQ, Schizotypal Personality Questionnaire.</p>
</table-wrap-foot>
</table-wrap>
<p>Regression analyses of the simple effects of RFQ scales on the presence of perceptive and cognitive BS showed that both RFQc (<italic>&#x03B2;</italic>&#x2009;=&#x2009;&#x2212;0.12, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 4.51, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) and RFQu (<italic>&#x03B2;</italic>&#x2009;=&#x2009;1.76, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 6.14, <italic>p</italic>&#x2009;=&#x2009;0.01) had statistically significant but again weak effects on cognitive BS (<xref rid="tab4" ref-type="table">Table 4</xref>). No significant independent effects of RFQ scales on perceptive BS were identified.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Logistic regression analyses of RFQ scales on perceptive and cognitive BS.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Dependent variables<break/>Independent variables</th>
<th align="center" valign="top"><italic>&#x03B2;</italic></th>
<th align="center" valign="top">SE</th>
<th align="center" valign="top">Wald (df&#x2009;=&#x2009;1)</th>
<th align="center" valign="top"><italic>p</italic></th>
<th align="center" valign="top">Exp(<italic>&#x03B2;</italic>)</th>
<th align="center" valign="top">95% CIs of Exp(<italic>&#x03B2;</italic>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="7"><italic>Perceptive BS</italic></td>
</tr>
<tr>
<td align="left" valign="top">RFQu</td>
<td align="char" valign="top" char=".">0.09</td>
<td align="char" valign="top" char=".">0.09</td>
<td align="char" valign="top" char=".">1.10</td>
<td align="char" valign="top" char=".">0.30</td>
<td align="char" valign="top" char=".">1.10</td>
<td align="char" valign="top" char=".">0.92; 1.31</td>
</tr>
<tr>
<td align="left" valign="top">RFQc</td>
<td align="char" valign="top" char=".">0.02</td>
<td align="char" valign="top" char=".">0.07</td>
<td align="char" valign="top" char=".">0.07</td>
<td align="char" valign="top" char=".">0.79</td>
<td align="char" valign="top" char=".">1.02</td>
<td align="char" valign="top" char=".">0.88; 1.18</td>
</tr>
<tr>
<td align="left" valign="top" char="." colspan="7"><italic>Cognitive BS</italic></td>
</tr>
<tr>
<td align="left" valign="top">RFQu</td>
<td align="char" valign="top" char=".">0.18</td>
<td align="char" valign="top" char=".">0.07</td>
<td align="char" valign="top" char=".">6.14</td>
<td align="char" valign="top" char="."><bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">1.19</td>
<td align="char" valign="top" char=".">1.04; 1.37</td>
</tr>
<tr>
<td align="left" valign="top">RFQc</td>
<td align="char" valign="top" char=".">&#x2212;0.12</td>
<td align="char" valign="top" char=".">0.06</td>
<td align="char" valign="top" char=".">4.51</td>
<td align="char" valign="top" char="."><bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">0.89</td>
<td align="char" valign="top" char=".">0.79; 0.99</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>BS, Basic Symptoms; RFQu, Reflective Functioning Questionnaire uncertainty about mental states; RFQc, Reflective Functioning Questionnaire certainty about mental states.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec13">
<label>3.3.</label>
<title>Interaction analyses</title>
<p>Because the odd speech and social anxiety SPQ subscales significantly accounted for the presence of perceptive and cognitive BS, respectively, two regression models were computed to examine the interaction effects of (a) SPQ odd speech with RFQ scales on perceptive BS and (b) SPQ social anxiety with RFQ scales on cognitive BS (<xref rid="tab5" ref-type="table">Table 5</xref>).</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Interaction analyses of SPQ subscales and RFQ scales on perceptive and cognitive BS.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Dependent variables</th>
<th align="left" valign="top">Independent variables</th>
<th align="center" valign="top">&#x03B2;</th>
<th align="center" valign="top">SE</th>
<th align="center" valign="top">Wald (df&#x2009;=&#x2009;1)</th>
<th align="center" valign="top"><italic>p</italic></th>
<th align="center" valign="top">Exp(&#x03B2;)</th>
<th align="center" valign="top">95% CIs of Exp(&#x03B2;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="8"><italic>Perceptive BS</italic></td>
</tr>
<tr>
<td rowspan="5"/>
<td align="left" valign="top">SPQ OddSp</td>
<td align="char" valign="top" char=".">0.23</td>
<td align="char" valign="top" char=".">0.12</td>
<td align="char" valign="top" char=".">3.71</td>
<td align="char" valign="top" char=".">0.05</td>
<td align="char" valign="top" char=".">1.26</td>
<td align="char" valign="top" char=".">1.00; 1.60</td>
</tr>
<tr>
<td align="left" valign="top">RFQc</td>
<td align="char" valign="top" char=".">0.09</td>
<td align="char" valign="top" char=".">0.09</td>
<td align="char" valign="top" char=".">1.05</td>
<td align="char" valign="top" char=".">0.31</td>
<td align="char" valign="top" char=".">1.09</td>
<td align="char" valign="top" char=".">0.92; 1.30</td>
</tr>
<tr>
<td align="left" valign="top">RFQu</td>
<td align="char" valign="top" char=".">0.14</td>
<td align="char" valign="top" char=".">0.11</td>
<td align="char" valign="top" char=".">1.67</td>
<td align="char" valign="top" char=".">0.20</td>
<td align="char" valign="top" char=".">1.15</td>
<td align="char" valign="top" char=".">0.93; 1.43</td>
</tr>
<tr>
<td align="left" valign="top">SPQ OddSp&#x002A;RFQc</td>
<td align="char" valign="top" char=".">&#x2212;0.05</td>
<td align="char" valign="top" char=".">0.03</td>
<td align="char" valign="top" char=".">4.28</td>
<td align="char" valign="top" char="."><bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">0.95</td>
<td align="char" valign="top" char=".">0.90; 1.00</td>
</tr>
<tr>
<td align="left" valign="top">SPQ OddSp&#x002A;RFQu</td>
<td align="char" valign="top" char=".">&#x2212;0.06</td>
<td align="center" valign="top">0.04</td>
<td align="char" valign="top" char=".">1.82</td>
<td align="char" valign="top" char=".">0.18</td>
<td align="char" valign="top" char=".">0.95</td>
<td align="char" valign="top" char=".">0.87; 1.03</td>
</tr>
<tr>
<td align="left" valign="top" colspan="8"><italic>Cognitive BS</italic></td>
</tr>
<tr>
<td rowspan="5"/>
<td align="left" valign="top">SPQ SocAnx</td>
<td align="char" valign="top" char=".">0.30</td>
<td align="char" valign="top" char=".">0.11</td>
<td align="char" valign="top" char=".">7.46</td>
<td align="char" valign="top" char="."><bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">1.35</td>
<td align="char" valign="top" char=".">1.09; 1.67</td>
</tr>
<tr>
<td align="left" valign="top">RFQc</td>
<td align="char" valign="top" char=".">&#x2212;0.04</td>
<td align="char" valign="top" char=".">0.08</td>
<td align="char" valign="top" char=".">0.20</td>
<td align="char" valign="top" char=".">0.66</td>
<td align="char" valign="top" char=".">0.96</td>
<td align="char" valign="top" char=".">0.82; 1.13</td>
</tr>
<tr>
<td align="left" valign="top">RFQu</td>
<td align="char" valign="top" char=".">0.07</td>
<td align="char" valign="top" char=".">0.10</td>
<td align="char" valign="top" char=".">0.51</td>
<td align="char" valign="top" char=".">0.48</td>
<td align="char" valign="top" char=".">1.07</td>
<td align="char" valign="top" char=".">0.89; 1.30</td>
</tr>
<tr>
<td align="left" valign="top">SPQ SocAnx&#x002A;RFQc</td>
<td align="char" valign="top" char=".">&#x2212;0.06</td>
<td align="char" valign="top" char=".">0.02</td>
<td align="char" valign="top" char=".">5.34</td>
<td align="char" valign="top" char="."><bold>&#x003C;0.05</bold></td>
<td align="char" valign="top" char=".">0.95</td>
<td align="char" valign="top" char=".">0.90; 0.99</td>
</tr>
<tr>
<td align="left" valign="top">SPQ SocAnx&#x002A;RFQu</td>
<td align="char" valign="top" char=".">&#x2212;0.01</td>
<td align="char" valign="top" char=".">0.05</td>
<td align="char" valign="top" char=".">0.04</td>
<td align="char" valign="top" char=".">0.84</td>
<td align="char" valign="top" char=".">0.99</td>
<td align="char" valign="top" char=".">0.91; 1.08</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>SPQ OddSp and SocAnx, Schizotypal Personality Questionnaire Odd Speech and Social Anxiety; RFQc and RFQu, Reflective Functioning Questionnaire Certainty and Uncertainty.</p>
</table-wrap-foot>
</table-wrap>
<p>Regression analyses revealed a significant interaction effect between SPQ odd speech and RFQc on perceptive BS (<italic>&#x03B2;</italic>&#x2009;=&#x2009;&#x2212;0.53, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 4.28, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05), indicating that the likelihood of experiencing perceptive BS was higher when SPQ odd speech was high and RFQc low (<xref rid="fig1" ref-type="fig">Figure 1</xref>). In addition, a significant interaction effect between SPQ social anxiety and RFQc on cognitive BS was found (<italic>&#x03B2;</italic>&#x2009;=&#x2009;&#x2212;0.57, <italic>Wald x</italic><sup>2</sup> <italic>(1)</italic> = 5.34, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). This revealed that the likelihood of experiencing cognitive BS was higher when SPQ social anxiety was high and RFQc was low (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Interaction between SPQ odd speech and RFQ certainty on perspective basic symptoms.</p>
</caption>
<graphic xlink:href="fpsyt-14-1267656-g001.tif"/>
</fig>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Interaction between SPQ social anxiety and RFQ certainty on basic symptoms.</p>
</caption>
<graphic xlink:href="fpsyt-14-1267656-g002.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussions" id="sec14">
<label>4.</label>
<title>Discussion</title>
<p>To the best of our knowledge, this is the first empirical investigation of the associations linking schizotypal traits, self-reported mentalizing and their interactions with the presence of basic symptoms (BS) included in CHR-P criteria. Findings indicate single associations of low effect size of disorganized and interpersonal schizotypal traits with perceptive and cognitive BS, respectively. Furthermore, self-reported mentalizing was independently associated with the presence of cognitive but not perceptive BS. Importantly, schizotypal trait features pertaining to odd speech and social anxiety were shown to interact with self-reported mentalizing difficulties, specifically low certainty in mental states, to account for the presence of perceptive and cognitive BS in our community adolescent and young adult sample. More specifically, results showed that the likelihood of experiencing perceptive BS was higher when odd speech was high and mentalizing certainty was low, while the likelihood of experiencing cognitive BS was higher when social anxiety was high and mentalizing certainty was low.</p>
<sec id="sec15">
<label>4.1.</label>
<title>Effects of schizotypal personality traits and self-reported mentalizing on perceptive and cognitive basic symptoms</title>
<p>The observed a significant association between schizotypal personality traits pertaining to odd speech and perceptive BS is in line with previous studies suggesting that disorganized speech relates to perceptual aberrations in people diagnosed with schizophrenia and non-clinical individuals, and that the two may be underpinned by shared neurobiological substrates (<xref ref-type="bibr" rid="ref48">48</xref>). Interestingly, two previous studies examining the neurofunctional correlates of schizotypal traits during adolescence in terms of resting-state functional connectivity reported a significant relationship between the disorganized dimension of the SPQ and neural activation in the auditory and visual networks (<xref ref-type="bibr" rid="ref49">49</xref>, <xref ref-type="bibr" rid="ref50">50</xref>). Thus, it might be relevant for future research to investigate the relationship between neural activation patterns, schizotypal traits and perceptive BS among CHR-P groups.</p>
<p>Furthermore, we found a positive association between schizotypal trait features pertaining to social anxiety and cognitive BS. Previous studies have reported higher levels of social phobia among UHR adolescent and young adult samples compared to non-clinical controls, with social phobia in UHR samples being associated to the severity of psychotic symptoms (<xref ref-type="bibr" rid="ref51">51</xref>). Importantly however, social phobia primarily involves worries about embarrassing oneself due to inadequate behavior, particularly in the eyes of unfamiliar people, while schizotypal social anxiety does not diminish with familiarity and tends to be associated with paranoid fears rather than negative judgments by others (<xref ref-type="bibr" rid="ref22">22</xref>). Interestingly, findings from a first-episode of psychosis sample suggest that social phobia and paranoid/persecutory ideation may cooccur during the early stages of clinical expression (<xref ref-type="bibr" rid="ref52">52</xref>). Furthermore, data from a structural equation modeling study showed that although negative schizotypy, mainly represented by social anxiety, was linked to cognitive BS in a CHR-P sample, positive schizotypy had a stronger association (<xref ref-type="bibr" rid="ref23">23</xref>). Thus, it might be speculated that it is the paranoid/persecutory nature of schizotypal social anxiety that drives the association with cognitive BS. This should be explored in future studies, comparing the association of schizotypal social anxiety and social phobia with cognitive BS. In addition, it might be relevant for future studies to explore whether factors previously shown to underpin social phobia among CHR-P samples, such as self-perceived stigma (<xref ref-type="bibr" rid="ref53">53</xref>), may also contribute in the relation between schizotypal social anxiety and cognitive BS. Nonetheless, from a clinical point of view, schizotypal social anxiety may constitute an important early prevention target to attenuate the development of CHR-P states.</p>
<p>The association of self-reported mentalizing difficulties (i.e., high uncertainty and low certainty in mental states) with the presence of cognitive BS is in line with a previous studies suggesting that mentalizing difficulties relate to psychosis-relevant thought problems in non-clinical adolescents (<xref ref-type="bibr" rid="ref38">38</xref>) and to aspects of cognitive disorganization in UHR adolescents and young adults (<xref ref-type="bibr" rid="ref37">37</xref>). Overall, it appears that mentalizing difficulties are linked to the presence of emerging state manifestations relevant for psychosis risk during adolescence and young adulthood, and may contribute to increased vulnerability for the illness.</p>
<p>Surprisingly, the results of the current study did not show an association of self-reported mentalizing with perceptive BS. This is in contrast to previous studies showing that mentalizing dysfunction relates to perceptual aberrations, such as hallucinations, in clinical psychosis and non-clinical samples (<xref ref-type="bibr" rid="ref40">40</xref>, <xref ref-type="bibr" rid="ref54">54</xref>). It must be noted however, that perceptive BS are clearly distinct from hallucinatory phenomena in that they are not subjectively perceived, at least initially, as external stimuli, but are rather immediately experienced as alterations in one&#x2019;s own visual and auditory senses, occurring in the perception of real stimuli (<xref ref-type="bibr" rid="ref46">46</xref>). Thus, it is possible that the association between mentalizing difficulties and perceptual aberrations may only become evident once the latter manifest in the form of attenuated auditory or visual hallucinations. Furthermore, previous studies suggesting associations between mentalizing problems and perceptual aberrations in clinical and non-clinical samples have employed task-based measures of mentalizing, which specifically capture the ability to attribute other peoples&#x2019; cognitions. In contrast the RFQ is a self-report measure designed to also capture self-oriented and affect-based aspects of mentalizing. Indeed, previous studies that have either used the RFQ in non-clinical samples or have used narrative-based methodologies to assess mentalizing in UHR samples did not report associations with perceptual abnormalities or hallucinatory phenomena (<xref ref-type="bibr" rid="ref37">37</xref>, <xref ref-type="bibr" rid="ref38">38</xref>). As such, methodological differences in the assessment of both mentalizing and perceptual symptoms may have accounted for the divergence from previous findings.</p>
</sec>
<sec id="sec16">
<label>4.2.</label>
<title>The role of reflective functioning in the relationship between schizotypal traits and basic symptoms</title>
<p>Results of the current study indicate that schizotypal trait features of social anxiety and odd speech, respectively, interacted with reduced certainty in mental states to account for the presence of cognitive and perceptive BS. In the case of cognitive BS, this interaction presented in addition to the single effect of schizotypal social anxiety, while in case of perceptive BS, only the interaction of mentalizing certainty and odd speech became significant.</p>
<p>The interaction between schizotypal trait features of social anxiety and mentalizing might elucidate some the underlying mechanisms linking schizotypal social anxiety with cognitive BS. In the context of failures to form adaptive representations of one&#x2019;s own and others&#x2019; mental states during interpersonal situations, schizotypal social anxiety may exert a disorganizing effect on cognitive functions (<xref ref-type="bibr" rid="ref55">55</xref>), which is putatively expressed as self-experienced cognitive BS. Furthermore, cognitive BS might further impair already present mentalizing difficulties, leading to a vicious circle of increasing mentalizing impairment and symptoms. Future studies should employ longitudinal designs to explore whether better mentalizing abilities exert a protective role against the development of cognitive BS among adolescents and young results who present with schizotypal trait features of social anxiety, and whether cognitive BS increase mentalizing difficulties.</p>
<p>Our findings also suggest that the likelihood of reporting the presence of perceptive BS in our sample was higher when odd speech was high and mentalizing certainty was low. Previous studies have shown that disorganization features of schizotypy, including odd speech, are prospectively linked to the developmental trajectory of clinically-relevant perceptual aberrations (<xref ref-type="bibr" rid="ref56">56</xref>). Our study adds to these findings by suggesting that difficulties in adaptively using mental states to understand one&#x2019;s own and others&#x2019; behaviors may contribute in the experience of perceptual aberrations among individuals presenting with disorganization features of schizotypy.</p>
<p>Overall, the current findings lend support to a model in which mentalizing difficulties contribute in the relation between schizotypal traits and CHR-P relevant symptoms. This resonates with data from Boldrini et al. (<xref ref-type="bibr" rid="ref37">37</xref>) who found that mentalizing dysfunctions related to symptoms of unusual thought content, persecutory ideas and disorganized communication, as well as increased the likelihood of future transition to a psychotic disorder in a UHR group of young adults. Thus, our results add to those of previous studies suggesting that mentalizing may contribute in modulating psychosis vulnerability across the continuum of its expression, from premorbid trait signs to state manifestations of psychosis risk and toward transition to a first clinical episode. Future studies with large samples may benefit by utilizing network analysis to further elucidate the complex nature of associations linking mentalizing dimensions, schizotypal traits and CHR-P.</p>
</sec>
<sec id="sec17">
<label>4.3.</label>
<title>Strengths and limitations</title>
<p>While the assessment in a community sample within the age range of highest risk of psychosis and the assessment of BS are clear strengths of our study, some limitations require careful interpretation of the results. First, the data were derived from a relatively small convenience sample and further associations of schizotypal traits and mentalizing with BS could have emerged with a larger more representative sample. In addition, cognitive and perceptive BS in the current study were only analyzed as categorical variables, according to their presence and absence. Thus, we did not examine the relation of schizotypal traits or self-reported mentalizing with the severity of BS, as the latter&#x2019;s distribution was biased toward low ratings due to the non-clinical nature of the sample. It must also be noted that due to the small sample size and convenience sampling method used, the distributions of certain sociodemographic variables assessed in the current study (i.e., participants&#x2019; occupational status and parental education) precluded their inclusion in the analyses as covariates. Similarly, we did not assess social risk factors previously shown to relate to CHR-P, such as childhood trauma (<xref ref-type="bibr" rid="ref57">57</xref>) and bullying victimization (<xref ref-type="bibr" rid="ref58">58</xref>), thus, it remains possible that these may have confounded the findings of the study. Furthermore, the cross-sectional nature of the study&#x2019;s design prevents us from drawing any causal conclusions about the relationships between the variables studied. Finally, on the basis of previous findings from a large representative Swiss community sample with much lower prevalence rates of cognitive and perceptive BS (<xref ref-type="bibr" rid="ref58">58</xref>), it is likely that our sample has been biased toward people already experiencing some mental health problems and, therefore, presenting with a 2&#x2013;3 times higher prevalence of BS.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec18">
<label>5.</label>
<title>Conclusion</title>
<p>Despite these limitations, the current study provides preliminary evidence on the relationship between trait and state manifestations relevant for psychosis risk and on the contribution of the psychological process of mentalizing to the relationship between the two. From a clinical standpoint, our results highlight that mentalizing abilities may be a worthwhile target of preventative interventions to sustain resilience against the development of BS and other risk states relevant for psychosis among adolescents and young adults who present with interpersonal and disorganization features of schizotypy.</p>
</sec>
<sec sec-type="data-availability" id="sec19">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="sec20" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Swissethics (Swiss Association of Research Ethics Committees) project number 2018-00251. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin.</p>
</sec>
<sec id="sec21">
<title>Author contributions</title>
<p>GS: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. ES-T: Data curation, Formal analysis, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. CM: Methodology, Writing &#x2013; review &#x0026; editing. LM: Data curation, Writing &#x2013; review &#x0026; editing, Formal analysis. SE: Conceptualization, Funding acquisition, Resources, Writing &#x2013; review &#x0026; editing. MA: Writing &#x2013; review &#x0026; editing. EF-P: Writing &#x2013; review &#x0026; editing. MD: Writing &#x2013; review &#x0026; editing. FS-L: Writing &#x2013; review &#x0026; editing, Methodology. DM: Conceptualization, Funding acquisition, Resources, Supervision, Writing &#x2013; review &#x0026; editing, Formal analysis, Methodology.</p>
</sec>
<sec sec-type="funding-information" id="sec22">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Swiss National Science Foundation (100019_159440) and the Gertrude Von Meissner Foundation (ME 7871). The publication of this manuscript was supported by the British Association for Counselling and Psychotherapy.</p>
</sec>
<sec sec-type="COI-statement" id="sec23">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>The authors wish to thank all the participants who kindly volunteered for this study and extend our special thanks to Deniz Kili&#x00E7;el for her help in proof reading early versions of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidman</surname><given-names>LJ</given-names></name> <name><surname>Nordentoft</surname><given-names>M</given-names></name></person-group>. <article-title>New targets for prevention of schizophrenia: is it time for interventions in the premorbid phase?</article-title> <source>Schizophr Bull</source>. (<year>2015</year>) <volume>41</volume>:<fpage>795</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1093/schbul/sbv050</pub-id>, PMID: <pub-id pub-id-type="pmid">25925393</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verdoux</surname><given-names>H</given-names></name> <name><surname>van Os</surname><given-names>J</given-names></name></person-group>. <article-title>Psychotic symptoms in non-clinical populations and the continuum of psychosis</article-title>. <source>Schizophr Res</source>. (<year>2002</year>) <volume>54</volume>:<fpage>59</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0920-9964(01)00352-8</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johns</surname><given-names>LC</given-names></name> <name><surname>Van Os</surname><given-names>J</given-names></name></person-group>. <article-title>The continuity of psychotic experiences in the general population</article-title>. <source>Clin Psychol Rev</source>. (<year>2001</year>) <volume>21</volume>:<fpage>1125</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0272-7358(01)00103-9</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamm</surname><given-names>JA</given-names></name> <name><surname>Leonhardt</surname><given-names>BL</given-names></name> <name><surname>Ridenour</surname><given-names>J</given-names></name> <name><surname>Lysaker</surname><given-names>JT</given-names></name> <name><surname>Lysaker</surname><given-names>PH</given-names></name></person-group>. <article-title>Phenomenological and recovery models of the subjective experience of psychosis: discrepancies and implications for treatment</article-title>. <source>Psychosis</source>. (<year>2018</year>) <volume>10</volume>:<fpage>340</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1080/17522439.2018.1522540</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armando</surname><given-names>M</given-names></name> <name><surname>Hutsebaut</surname><given-names>J</given-names></name> <name><surname>Debban&#x00E9;</surname><given-names>M</given-names></name></person-group>. <article-title>A mentalization-informed staging approach to clinical high risk for psychosis</article-title>. <source>Front Psych</source>. (<year>2019</year>) <volume>10</volume>:<fpage>385</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00385</pub-id>, PMID: <pub-id pub-id-type="pmid">31214062</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murru</surname><given-names>A</given-names></name> <name><surname>Carpiniello</surname><given-names>B</given-names></name></person-group>. <article-title>Duration of untreated illness as a key to early intervention in schizophrenia: a review</article-title>. <source>Neurosci Lett</source>. (<year>2018</year>) <volume>669</volume>:<fpage>59</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neulet.2016.10.003</pub-id>, PMID: <pub-id pub-id-type="pmid">27717830</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ising</surname><given-names>HK</given-names></name> <name><surname>Smit</surname><given-names>F</given-names></name> <name><surname>Veling</surname><given-names>W</given-names></name> <name><surname>Rietdijk</surname><given-names>J</given-names></name> <name><surname>Dragt</surname><given-names>S</given-names></name> <name><surname>Klaassen</surname><given-names>RMC</given-names></name> <etal/></person-group>. <article-title>Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-Centre randomized controlled trial</article-title>. <source>Psychol Med</source>. (<year>2015</year>) <volume>45</volume>:<fpage>1435</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0033291714002530</pub-id>, PMID: <pub-id pub-id-type="pmid">25330734</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Schmidt</surname><given-names>SJ</given-names></name></person-group>. <article-title>&#x00C4;tiologie der Psychosen &#x2013; Aktueller stand [etiology of psychoses &#x2013; current state]</article-title>. <source>Psychotherapie im Dialog</source>. (<year>2015</year>) <volume>16</volume>:<fpage>16</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0041-102234</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Michel</surname><given-names>C</given-names></name> <name><surname>Schmidt</surname><given-names>SJ</given-names></name> <name><surname>Schimmelmann</surname><given-names>BG</given-names></name> <name><surname>Maric</surname><given-names>NP</given-names></name> <name><surname>Salokangas</surname><given-names>RK</given-names></name> <etal/></person-group>. <article-title>EPA guidance on the early detection of clinical high risk states of psychoses</article-title>. <source>Eur Psychiatry</source>. (<year>2015</year>) <volume>30</volume>:<fpage>405</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.eurpsy.2015.01.010</pub-id>, PMID: <pub-id pub-id-type="pmid">25735810</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fusar-Poli</surname><given-names>P</given-names></name> <name><surname>Borgwardt</surname><given-names>S</given-names></name> <name><surname>Bechdolf</surname><given-names>A</given-names></name> <name><surname>Addington</surname><given-names>J</given-names></name> <name><surname>Riecher-R&#x00F6;ssler</surname><given-names>A</given-names></name> <name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <etal/></person-group>. <article-title>The psychosis high-risk state: a comprehensive state-of-the-art review</article-title>. <source>JAMA Psychiatry</source>. (<year>2013</year>) <volume>70</volume>:<fpage>107</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.269</pub-id>, PMID: <pub-id pub-id-type="pmid">23165428</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Klosterk&#x00F6;tter</surname><given-names>J</given-names></name> <name><surname>Picker</surname><given-names>H</given-names></name> <name><surname>Steinmeyer</surname><given-names>EM</given-names></name> <name><surname>Ruhrmann</surname><given-names>S</given-names></name></person-group>. <article-title>Predicting first-episode psychosis by basic symptom criteria</article-title>. <source>Clin Neuropsychiatry</source>. (<year>2007</year>) <volume>4</volume>:<fpage>11</fpage>&#x2013;<lpage>22</lpage>.</citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Ruhrmann</surname><given-names>S</given-names></name> <name><surname>Fusar-Poli</surname><given-names>P</given-names></name> <name><surname>Bechdolf</surname><given-names>A</given-names></name> <name><surname>Schimmelmann</surname><given-names>BG</given-names></name> <name><surname>Klosterkotter</surname><given-names>J</given-names></name></person-group>. <article-title>Basic symptoms and the prediction of first-episode psychosis</article-title>. <source>Curr Pharm Des</source>. (<year>2012</year>) <volume>18</volume>:<fpage>351</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.2174/138161212799316064</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>AE</given-names></name> <name><surname>Borgwardt</surname><given-names>S</given-names></name> <name><surname>Riecher-R&#x00F6;ssler</surname><given-names>A</given-names></name> <name><surname>Velthorst</surname><given-names>E</given-names></name> <name><surname>de Haan</surname><given-names>L</given-names></name> <name><surname>Fusar-Poli</surname><given-names>P</given-names></name></person-group>. <article-title>Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis</article-title>. <source>Psychiatry Res</source>. (<year>2013</year>) <volume>209</volume>:<fpage>266</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psychres.2013.03.004</pub-id>, PMID: <pub-id pub-id-type="pmid">23871169</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>C</given-names></name> <name><surname>Toffel</surname><given-names>E</given-names></name> <name><surname>Schmidt</surname><given-names>SJ</given-names></name> <name><surname>Eliez</surname><given-names>S</given-names></name> <name><surname>Armando</surname><given-names>M</given-names></name> <name><surname>Solida-Tozzi</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>D&#x00E9;tection et traitement pr&#x00E9;coce des sujets &#x00E0; haut risque clinique de psychose: d&#x00E9;finitions et recommandations</article-title>. <source>L'Enc&#x00E9;phale</source>. (<year>2017</year>) <volume>43</volume>:<fpage>292</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.encep.2017.01.005</pub-id>, PMID: <pub-id pub-id-type="pmid">28347521</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGorry</surname><given-names>PD</given-names></name> <name><surname>Purcell</surname><given-names>R</given-names></name> <name><surname>Hickie</surname><given-names>IB</given-names></name> <name><surname>Yung</surname><given-names>AR</given-names></name> <name><surname>Pantelis</surname><given-names>C</given-names></name> <name><surname>Jackson</surname><given-names>HJ</given-names></name></person-group>. <article-title>Clinical staging: a heuristic model for psychiatry and youth mental health</article-title>. <source>Med J Aust</source>. (<year>2007</year>) <volume>187</volume>:<fpage>S40</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.5694/j.1326-5377.2007.tb01335.x</pub-id>, PMID: <pub-id pub-id-type="pmid">17908024</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fusar-Poli</surname><given-names>P</given-names></name> <name><surname>de Pablo</surname><given-names>GS</given-names></name> <name><surname>Correll</surname><given-names>CU</given-names></name> <name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name> <name><surname>Millan</surname><given-names>MJ</given-names></name> <name><surname>Borgwardt</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Prevention of psychosis: advances in detection, prognosis, and intervention</article-title>. <source>JAMA Psychiatry</source>. (<year>2020</year>) <volume>77</volume>:<fpage>755</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.4779</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Worthington</surname><given-names>MA</given-names></name> <name><surname>Cannon</surname><given-names>TD</given-names></name></person-group>. <article-title>Prediction and prevention in the clinical high-risk for psychosis paradigm: a review of the current status and recommendations for future directions of inquiry</article-title>. <source>Front Psych</source>. (<year>2021</year>) <volume>12</volume>:<fpage>770774</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2021.770774</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fl&#x00FC;ckiger</surname><given-names>R</given-names></name> <name><surname>Ruhrmann</surname><given-names>S</given-names></name> <name><surname>Debban&#x00E9;</surname><given-names>M</given-names></name> <name><surname>Michel</surname><given-names>C</given-names></name> <name><surname>Hubl</surname><given-names>D</given-names></name> <name><surname>Schimmelmann</surname><given-names>BG</given-names></name> <etal/></person-group>. <article-title>Psychosis-predictive value of self-reported schizotypy in a clinical high risk sample</article-title>. <source>J Abnorm Psychol</source>. (<year>2016</year>) <volume>125</volume>:<fpage>923</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1037/abn0000192</pub-id>, PMID: <pub-id pub-id-type="pmid">27583768</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Lenzenweger</surname><given-names>MF</given-names></name></person-group>. <source>Schizotypy and schizophrenia: the view from experimental psychology</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>The Guilford Press</publisher-name> (<year>2010</year>).</citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meehl</surname><given-names>PE</given-names></name></person-group>. <article-title>Schizotaxia, schizotypy, schizophrenia</article-title>. <source>Am Psychol</source>. (<year>1962</year>) <volume>17</volume>:<fpage>827</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1037/h0041029</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>C</given-names></name> <name><surname>Fl&#x00FC;ckiger</surname><given-names>R</given-names></name> <name><surname>Kindler</surname><given-names>J</given-names></name> <name><surname>Hubl</surname><given-names>D</given-names></name> <name><surname>Kaess</surname><given-names>M</given-names></name> <name><surname>Schultze-Lutter</surname><given-names>F</given-names></name></person-group>. <article-title>The trait-state distinction of schizotypy and clinical high risk: results from a 1-year follow-up</article-title>. <source>World Psychiatry</source>. (<year>2018</year>) <volume>18</volume>:<fpage>108</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1002/wps.20595</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Nenadic</surname><given-names>I</given-names></name> <name><surname>Grant</surname><given-names>P</given-names></name></person-group>. <article-title>Psychosis and schizophrenia-spectrum personality disorders require early detection on different symptom dimensions</article-title>. <source>Front Psych</source>. (<year>2019</year>) <volume>10</volume>:<fpage>476</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00476</pub-id>, PMID: <pub-id pub-id-type="pmid">31354543</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fl&#x00FC;ckiger</surname><given-names>R</given-names></name> <name><surname>Michel</surname><given-names>C</given-names></name> <name><surname>Grant</surname><given-names>P</given-names></name> <name><surname>Ruhrmann</surname><given-names>S</given-names></name> <name><surname>Vogeley</surname><given-names>K</given-names></name> <name><surname>Hubl</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: cognitive disturbances matter</article-title>. <source>Schizophr Res</source>. (<year>2019</year>) <volume>210</volume>:<fpage>188</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.schres.2018.12.039</pub-id>, PMID: <pub-id pub-id-type="pmid">30683524</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fonseca-Pedrero</surname><given-names>E</given-names></name> <name><surname>Debban&#x00E9;</surname><given-names>M</given-names></name> <name><surname>Ortu&#x00F1;o-Sierra</surname><given-names>J</given-names></name> <name><surname>Chan</surname><given-names>RCK</given-names></name> <name><surname>Cicero</surname><given-names>DC</given-names></name></person-group>. <article-title>The structure of schizotypal personality traits: a cross-national study</article-title>. <source>Psychol Med</source>. (<year>2018</year>) <volume>48</volume>:<fpage>451</fpage>&#x2013;<lpage>462</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0033291717001829</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debban&#x00E9;</surname><given-names>M</given-names></name> <name><surname>Eliez</surname><given-names>S</given-names></name> <name><surname>Badoud</surname><given-names>D</given-names></name> <name><surname>Conus</surname><given-names>P</given-names></name> <name><surname>Fluckiger</surname><given-names>R</given-names></name> <name><surname>Schultze-Lutter</surname><given-names>F</given-names></name></person-group>. <article-title>Developing psychosis and its risk states through the lens of schizotypy</article-title>. <source>Schizophr Bull</source>. (<year>2015</year>) <volume>41</volume>:<fpage>S396</fpage>&#x2013;<lpage>407</lpage>. doi: <pub-id pub-id-type="doi">10.1093/schbul/sbu176</pub-id>, PMID: <pub-id pub-id-type="pmid">25548386</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boldrini</surname><given-names>T</given-names></name> <name><surname>Tanzilli</surname><given-names>A</given-names></name> <name><surname>Di Cicilia</surname><given-names>G</given-names></name> <name><surname>Gualco</surname><given-names>I</given-names></name> <name><surname>Lingiardi</surname><given-names>V</given-names></name> <name><surname>Salcuni</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Personality traits and disorders in adolescents at clinical high risk for psychosis: toward a clinically meaningful diagnosis</article-title>. <source>Front Psych</source>. (<year>2020</year>) <volume>11</volume>:<fpage>562835</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2020.562835</pub-id>, PMID: <pub-id pub-id-type="pmid">33363479</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goulding</surname><given-names>A</given-names></name></person-group>. <article-title>Schizotypy models in relation to subjective health and paranormal beliefs and experiences</article-title>. <source>Personal Individ Differ</source>. (<year>2004</year>) <volume>37</volume>:<fpage>157</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.paid.2003.08.008</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawlings</surname><given-names>D</given-names></name> <name><surname>Williams</surname><given-names>B</given-names></name> <name><surname>Haslem</surname><given-names>N</given-names></name> <name><surname>Claridge</surname><given-names>G</given-names></name></person-group>. <article-title>Taxometric analysis supports a dimensional latent structure for schizotypy</article-title>. <source>Personal Individ Differ</source>. (<year>2008</year>) <volume>44</volume>:<fpage>1640</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.paid.2007.06.005</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debbane</surname><given-names>M</given-names></name> <name><surname>Barrantes-Vidal</surname><given-names>N</given-names></name></person-group>. <article-title>Schizotypy from a developmental perspective</article-title>. <source>Schizophr Bull</source>. (<year>2015</year>) <volume>41</volume>:<fpage>S386</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1093/schbul/sbu175</pub-id>, PMID: <pub-id pub-id-type="pmid">25548385</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Debbane</surname><given-names>M</given-names></name> <name><surname>Theodoridou</surname><given-names>A</given-names></name> <name><surname>Wood</surname><given-names>SJ</given-names></name> <name><surname>Raballo</surname><given-names>A</given-names></name> <name><surname>Michel</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>Revisiting the basic symptom concept: toward translating risk symptoms for psychosis into neurobiological targets</article-title>. <source>Front Psych</source>. (<year>2016</year>) <volume>7</volume>:<fpage>9</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2016.00009</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Fonagy</surname><given-names>P</given-names></name> <name><surname>Gergely</surname><given-names>G</given-names></name> <name><surname>Jurist</surname><given-names>EL</given-names></name> <name><surname>Target</surname><given-names>M</given-names></name></person-group>. <source>Affect regulation, Mentalization, and the development of the self</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Other Press</publisher-name> (<year>2002</year>).</citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debbane</surname><given-names>M</given-names></name> <name><surname>Salaminios</surname><given-names>G</given-names></name> <name><surname>Luyten</surname><given-names>P</given-names></name> <name><surname>Badoud</surname><given-names>D</given-names></name> <name><surname>Armando</surname><given-names>M</given-names></name> <name><surname>Solida Tozzi</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Attachment, neurobiology, and Mentalizing along the psychosis continuum</article-title>. <source>Front Hum Neurosci</source>. (<year>2016</year>) <volume>10</volume>:<fpage>406</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnhum.2016.00406</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Brent</surname><given-names>BK</given-names></name> <name><surname>Fonagy</surname><given-names>P</given-names></name></person-group>. <article-title>A mentalization-based treatment approach to disturbances of social understanding in schizophrenia</article-title> In: <person-group person-group-type="editor"><name><surname>Lysaker</surname> <given-names>PH</given-names></name> <name><surname>Dimaggio</surname> <given-names>G</given-names></name> <name><surname>Brune</surname> <given-names>M</given-names></name></person-group>, editors. <source>Social cognition and metacognition in schizophrenia: Psychopathology and treatment approaches</source>. <publisher-loc>Gurgaon</publisher-loc>: <publisher-name>Elsevier Science and Technology</publisher-name> (<year>2014</year>).</citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Salaminios</surname><given-names>G</given-names></name> <name><surname>Debban&#x00E9;</surname><given-names>M</given-names></name></person-group>. <article-title>A Mentalization-based treatment framework to support the recovery of the self in emerging psychosis during adolescence</article-title> In: <source>The recovery of the self in psychosis</source>. <person-group person-group-type="editor"><name><surname>Hasson-Ohayon</surname> <given-names>I</given-names></name> <name><surname>Lysaker</surname> <given-names>PH</given-names></name></person-group>, editors. <publisher-loc>London</publisher-loc>: <publisher-name>Routledge</publisher-name> (<year>2021</year>).</citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>E</given-names></name> <name><surname>Pantelis</surname><given-names>C</given-names></name></person-group>. <article-title>Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis</article-title>. <source>Schizophr Res</source>. (<year>2013</year>) <volume>144</volume>:<fpage>31</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.schres.2012.12.013</pub-id>, PMID: <pub-id pub-id-type="pmid">23347949</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sprong</surname><given-names>M</given-names></name> <name><surname>Schothorst</surname><given-names>P</given-names></name> <name><surname>Vos</surname><given-names>E</given-names></name> <name><surname>Hox</surname><given-names>J</given-names></name> <name><surname>Van Engeland</surname><given-names>H</given-names></name></person-group>. <article-title>Theory of mind in schizophrenia: meta-analysis</article-title>. <source>Br J Psychiatry</source>. (<year>2007</year>) <volume>191</volume>:<fpage>5</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1192/bjp.bp.107.035899</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boldrini</surname><given-names>T</given-names></name> <name><surname>Pontillo</surname><given-names>M</given-names></name> <name><surname>Tanzilli</surname><given-names>A</given-names></name> <name><surname>Giovanardi</surname><given-names>G</given-names></name> <name><surname>Di Cicilia</surname><given-names>G</given-names></name> <name><surname>Salcuni</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>An attachment perspective on the risk for psychosis: clinical correlates and the predictive value of attachment patterns and mentalization</article-title>. <source>Schizophr Res</source>. (<year>2020</year>) <volume>222</volume>:<fpage>209</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.schres.2020.05.052</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salaminios</surname><given-names>G</given-names></name> <name><surname>Morosan</surname><given-names>L</given-names></name> <name><surname>Toffel</surname><given-names>E</given-names></name> <name><surname>Tanzer</surname><given-names>M</given-names></name> <name><surname>Eliez</surname><given-names>S</given-names></name> <name><surname>Badoud</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>Associations between schizotypal personality features, mentalizing difficulties and thought problems in a sample of community adolescents</article-title>. <source>Early Interv Psychiatry</source>. (<year>2021</year>) <volume>15</volume>:<fpage>705</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1111/eip.13011</pub-id>, PMID: <pub-id pub-id-type="pmid">32573985</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langdon</surname><given-names>R</given-names></name> <name><surname>Coltheart</surname><given-names>M</given-names></name></person-group>. <article-title>Mentalising, schizotypy, and schizophrenia</article-title>. <source>Cognition</source>. (<year>1999</year>) <volume>71</volume>:<fpage>43</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0010-0277(99)00018-9</pub-id>, PMID: <pub-id pub-id-type="pmid">10394709</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pickup</surname><given-names>G</given-names></name></person-group>. <article-title>Theory of mind and its relation to schizotypy</article-title>. <source>Cogn Neuropsychiatry</source>. (<year>2006</year>) <volume>11</volume>:<fpage>117</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1080/13546800444000236</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartels-Velthuis</surname><given-names>AA</given-names></name> <name><surname>Blijd-Hoogewys</surname><given-names>EM</given-names></name> <name><surname>van Os</surname><given-names>J</given-names></name></person-group>. <article-title>Better theory-of-mind skills in children hearing voices mitigate the risk of secondary delusion formation</article-title>. <source>Acta Psychiatr Scand</source>. (<year>2011</year>) <volume>124</volume>:<fpage>193</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1600-0447.2011.01699.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21426312</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>P</given-names></name> <name><surname>Bouafia</surname><given-names>S</given-names></name> <name><surname>Gutknecht</surname><given-names>C</given-names></name> <name><surname>Saoud</surname><given-names>M</given-names></name> <name><surname>Dalery</surname><given-names>J</given-names></name> <name><surname>d'Amato</surname><given-names>T</given-names></name></person-group>. <article-title>Validation of the French version of the Raine schizotypal personality disorder questionnaire</article-title>. <source>L'Enc&#x00E9;phale</source>. (<year>2000</year>) <volume>26</volume>:<fpage>23</fpage>&#x2013;<lpage>9</lpage>. PMID: <pub-id pub-id-type="pmid">11192801</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badoud</surname><given-names>D</given-names></name> <name><surname>Chanal</surname><given-names>J</given-names></name> <name><surname>Eliez</surname><given-names>S</given-names></name> <name><surname>Van Der Linden</surname><given-names>M</given-names></name> <name><surname>Debban&#x00E9;</surname><given-names>M</given-names></name></person-group>. <article-title>Validation study of the french schizotypal personality questionnaire in an sample of adolescents; a confirmatory factor analysis</article-title>. <source>L'Enc&#x00E9;phale</source>. (<year>2011</year>) <volume>37</volume>:<fpage>299</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.encep.2010.08.017</pub-id>, PMID: <pub-id pub-id-type="pmid">21981891</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badoud</surname><given-names>D</given-names></name> <name><surname>Luyten</surname><given-names>P</given-names></name> <name><surname>Fonseca-Pedrero</surname><given-names>E</given-names></name> <name><surname>Eliez</surname><given-names>S</given-names></name> <name><surname>Fonagy</surname><given-names>P</given-names></name> <name><surname>Debbane</surname><given-names>M</given-names></name></person-group>. <article-title>The French version of the reflective functioning questionnaire: validity data for adolescents and adults and its association with non-suicidal self-injury</article-title>. <source>PLoS One</source>. (<year>2015</year>) <volume>10</volume>:<fpage>e0145892</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0145892</pub-id>, PMID: <pub-id pub-id-type="pmid">26714319</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fonagy</surname><given-names>P</given-names></name> <name><surname>Luyten</surname><given-names>P</given-names></name> <name><surname>Moulton-Perkins</surname><given-names>A</given-names></name> <name><surname>Lee</surname><given-names>YW</given-names></name> <name><surname>Warren</surname><given-names>F</given-names></name> <name><surname>Howard</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Development and validation of a self-report measure of Mentalizing: the reflective functioning questionnaire</article-title>. <source>PLoS One</source>. (<year>2016</year>) <volume>11</volume>:<fpage>e0158678</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0158678</pub-id>, PMID: <pub-id pub-id-type="pmid">27392018</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Addington</surname><given-names>J</given-names></name> <name><surname>Ruhrmann</surname><given-names>S</given-names></name> <name><surname>Klosterkkotter</surname><given-names>J</given-names></name></person-group> (<year>2007</year>). <article-title>Schizophrenia proneness instrument</article-title>, <comment>Adult version (SPI-A). Giovanni, F., Roma</comment>.</citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Koch</surname><given-names>E</given-names></name></person-group>, (<year>2010</year>). <article-title>Schizophrenia proneness instrument, child and youth version (SPI-CY)</article-title>. <comment>Giovanni, F., Roma</comment>.</citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>IE</given-names></name> <name><surname>Derwort</surname><given-names>AM</given-names></name> <name><surname>Daalman</surname><given-names>K</given-names></name> <name><surname>de Weijer</surname><given-names>AD</given-names></name> <name><surname>Liddle</surname><given-names>PF</given-names></name> <name><surname>Boks</surname><given-names>MP</given-names></name></person-group>. <article-title>Formal thought disorder in non-clinical individuals with auditory verbal hallucinations</article-title>. <source>Schizophr Res</source>. (<year>2010</year>) <volume>118</volume>:<fpage>140</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.schres.2010.01.024</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Derome</surname><given-names>M</given-names></name> <name><surname>Fonseca-Pedrero</surname><given-names>E</given-names></name> <name><surname>Badoud</surname><given-names>D</given-names></name> <name><surname>Morosan</surname><given-names>L</given-names></name> <name><surname>Van de Ville</surname><given-names>D</given-names></name> <name><surname>Lazeyras</surname><given-names>F</given-names></name> <etal/></person-group>. <article-title>Resting-state networks of adolescents experiencing depersonalization-like illusions: cross-sectional and longitudinal findings</article-title>. <source>Schizophr Bull</source>. (<year>2018</year>) <volume>44</volume>:<fpage>S501</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1093/schbul/sby031</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lagioia</surname><given-names>A</given-names></name> <name><surname>Van De Ville</surname><given-names>D</given-names></name> <name><surname>Debbane</surname><given-names>M</given-names></name> <name><surname>Lazeyras</surname><given-names>F</given-names></name> <name><surname>Eliez</surname><given-names>S</given-names></name></person-group>. <article-title>Adolescent resting state networks and their associations with schizotypal trait expression</article-title>. <source>Front Syst Neurosci</source>. (<year>2010</year>) <volume>4</volume>:<fpage>35</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnsys.2010.00035</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pontillo</surname><given-names>M</given-names></name> <name><surname>Guerrera</surname><given-names>S</given-names></name> <name><surname>Santonastaso</surname><given-names>O</given-names></name> <name><surname>Tata</surname><given-names>MC</given-names></name> <name><surname>Averna</surname><given-names>R</given-names></name> <name><surname>Vicari</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>An overview of recent findings on social anxiety disorder in adolescents and young adults at clinical high risk for psychosis</article-title>. <source>Brain Sci</source>. (<year>2017</year>) <volume>7</volume>:<fpage>127</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci7100127</pub-id>, PMID: <pub-id pub-id-type="pmid">29019916</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michail</surname><given-names>M</given-names></name> <name><surname>Birchwood</surname><given-names>M</given-names></name></person-group>. <article-title>Social anxiety disorder in first-episode psychosis: incidence, phenomenology and relationship with paranoia</article-title>. <source>Br J Psychiatry</source>. (<year>2009</year>) <volume>195</volume>:<fpage>234</fpage>&#x2013;<lpage>1</lpage>. doi: <pub-id pub-id-type="doi">10.1192/bjp.bp.108.053124</pub-id>, PMID: <pub-id pub-id-type="pmid">19721113</pub-id></citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aunjitsakul</surname><given-names>W</given-names></name> <name><surname>McGuire</surname><given-names>N</given-names></name> <name><surname>McLeod</surname><given-names>HJ</given-names></name> <name><surname>Gumley</surname><given-names>A</given-names></name></person-group>. <article-title>Candidate factors maintaining social anxiety in the context of psychotic experiences: a systematic review</article-title>. <source>Schizophr Bull</source>. (<year>2021</year>) <volume>47</volume>:<fpage>1218</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1093/schbul/sbab026</pub-id>, PMID: <pub-id pub-id-type="pmid">33778868</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marjoram</surname><given-names>D</given-names></name> <name><surname>Gardner</surname><given-names>C</given-names></name> <name><surname>Burns</surname><given-names>J</given-names></name> <name><surname>Miller</surname><given-names>P</given-names></name> <name><surname>Lawrie</surname><given-names>S</given-names></name> <name><surname>Johnstone</surname><given-names>E</given-names></name></person-group>. <article-title>Symptomatology and social inference: a theory of mind study of schizophrenia and psychotic affective disorder</article-title>. <source>Cogn Neuropsychiatry</source>. (<year>2005</year>) <volume>10</volume>:<fpage>347</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1080/13546800444000092</pub-id>, PMID: <pub-id pub-id-type="pmid">16571466</pub-id></citation></ref>
<ref id="ref55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vodu&#x0161;ek</surname><given-names>VV</given-names></name> <name><surname>Parnas</surname><given-names>J</given-names></name> <name><surname>Tomori</surname><given-names>M</given-names></name> <name><surname>&#x0160;kodlar</surname><given-names>B</given-names></name></person-group>. <article-title>The phenomenology of emotion experience in first-episode psychosis</article-title>. <source>Psychopathology</source>. (<year>2014</year>) <volume>47</volume>:<fpage>252</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000357759</pub-id>, PMID: <pub-id pub-id-type="pmid">24481376</pub-id></citation></ref>
<ref id="ref56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>MDG</given-names></name> <name><surname>Saka</surname><given-names>MC</given-names></name> <name><surname>Lieb</surname><given-names>R</given-names></name> <name><surname>Wittchen</surname><given-names>HU</given-names></name> <name><surname>van Os</surname><given-names>J</given-names></name></person-group>. <article-title>Early expression of negative/disorganized symptoms predicting psychotic experiences and 265 subsequent clinical psychosis: a 10-year study</article-title>. <source>Am J Psychiatr</source>. (<year>2010</year>) <volume>167</volume>:<fpage>1075</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1176/appi.ajp.2010.09060883</pub-id>, PMID: <pub-id pub-id-type="pmid">20634371</pub-id></citation></ref>
<ref id="ref57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayo</surname><given-names>D</given-names></name> <name><surname>Corey</surname><given-names>S</given-names></name> <name><surname>Kelly</surname><given-names>LH</given-names></name> <name><surname>Yohannes</surname><given-names>S</given-names></name> <name><surname>Youngquist</surname><given-names>AL</given-names></name> <name><surname>Stuart</surname><given-names>BK</given-names></name> <etal/></person-group>. <article-title>The role of trauma and stressful life events among individuals at clinical high risk for psychosis: a review</article-title>. <source>Front Psych</source>. (<year>2017</year>) <volume>8</volume>:<fpage>55</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2017.00055</pub-id>, PMID: <pub-id pub-id-type="pmid">28473776</pub-id></citation></ref>
<ref id="ref58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>A</given-names></name> <name><surname>Liu</surname><given-names>L</given-names></name> <name><surname>Bearden</surname><given-names>CE</given-names></name> <name><surname>Cadenhead</surname><given-names>KS</given-names></name> <name><surname>Cornblatt</surname><given-names>BA</given-names></name> <name><surname>Keshavan</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source>. (<year>2022</year>) <volume>57</volume>:<fpage>1379</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00127-022-02239-5</pub-id>, PMID: <pub-id pub-id-type="pmid">35113189</pub-id></citation></ref>
<ref id="ref59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Lutter</surname><given-names>F</given-names></name> <name><surname>Ruhrmann</surname><given-names>S</given-names></name> <name><surname>Michel</surname><given-names>C</given-names></name> <name><surname>Kindler</surname><given-names>J</given-names></name> <name><surname>Schimmelmann</surname><given-names>BG</given-names></name> <name><surname>Schmidt</surname><given-names>SJ</given-names></name></person-group>. <article-title>Age effects on basic symptoms in the community: a route to gain new insight into the neurodevelopment of psychosis?</article-title> <source>Eur Arch Psychiatry Clin Neurosci</source>. (<year>2020</year>) <volume>270</volume>:<fpage>311</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00406-018-0949-4</pub-id>, PMID: <pub-id pub-id-type="pmid">30361925</pub-id></citation></ref>
</ref-list>
</back>
</article>